Cite
BRD4 inhibitor GNE987 exerts anti-cancer effects by targeting super-enhancers in neuroblastoma
MLA
Yan-Ling Chen, et al. “BRD4 Inhibitor GNE987 Exerts Anti-Cancer Effects by Targeting Super-Enhancers in Neuroblastoma.” Cell & Bioscience, vol. 12, no. 1, Mar. 2022, pp. 1–20. EBSCOhost, https://doi.org/10.1186/s13578-022-00769-8.
APA
Yan-Ling Chen, Xiao-Lu Li, Gen Li, Yan-Fang Tao, Ran Zhuo, Hai-Bo Cao, Wan-yan Jiao, Zhi-Heng Li, Zhen-Hong Zhu, Fang Fang, Yi Xie, Xin-Mei Liao, Di Wu, Hai-Rong Wang, Juan-Juan Yu, Si-Qi Jia, Yang Yang, Chen-Xi Feng, Peng-Cheng Yang, … Jian Pan. (2022). BRD4 inhibitor GNE987 exerts anti-cancer effects by targeting super-enhancers in neuroblastoma. Cell & Bioscience, 12(1), 1–20. https://doi.org/10.1186/s13578-022-00769-8
Chicago
Yan-Ling Chen, Xiao-Lu Li, Gen Li, Yan-Fang Tao, Ran Zhuo, Hai-Bo Cao, Wan-yan Jiao, et al. 2022. “BRD4 Inhibitor GNE987 Exerts Anti-Cancer Effects by Targeting Super-Enhancers in Neuroblastoma.” Cell & Bioscience 12 (1): 1–20. doi:10.1186/s13578-022-00769-8.